Huang Xiuting, Lin Kehai, Chen Weirui, Zhang Donghui, Khan Muhammad, Ye Xiaoxin, Wang Baiyao, Chen Chengcong, Tian Yunhong, Yuan Yawei, Lin Jie
Department of Radiation Oncology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510000, China.
Department of Oncology, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou 510000, China.
Radiother Oncol. 2025 Feb;203:110686. doi: 10.1016/j.radonc.2024.110686. Epub 2024 Dec 19.
Radiotherapy presents a curative approach for nasopharyngeal carcinoma (NPC); however, the cellular radiosensitivity heterogeneity limits its efficacy. Thus, investigating the specific mechanisms of radioresistance in NPC is crucial for identifying and employing effective radiosensitizing agents to enhance treatment success.
Radioresistant NPC cell lines HONE1-RR and SUNE1-RR were established. Quantitative reverse transcription-PCR (qRT-PCR), western blot, and enzyme-linked immuno sorbent assay (ELISA) were employed to detect the activation of the angiotensinogen (AGT) and local angiotensin II (Ang II). Transmission electron microscopy, ferrous ion detection, and lipid oxidation levels were utilized to detect radiation-induced ferroptosis in NPC. Bioinformatics analysis, along with qRT-PCR, western blotting, co-immunoprecipitation, and dual-luciferase assays were employed to explore downstream mechanisms. Colony formation assay, Cell Counting Kit-8 (CCK-8) assay, and a nude mouse xenograft model were utilized to assess NPC radiosensitivity. The expression of AGT, hypoxia-inducible factor-1 alpha (HIF-1α), hypoxia-inducible lipid droplet-associated protein (HILPDA), and glutathione peroxidase 4 (GPX4) in NPC tissues was detected through immunohistochemistry.
Activation of local Ang II was revealed to play a critical role in driving radioresistance in NPC cells modulating ferroptosis. This local Ang II established a positive feedback loop with HIF-1α through two parallel pathways; Ang II stabilizes HIF-1α by activating the MAPK pathway, and AGT directly binds HIF-1α to prevent its degradation. This AGT-HIF-1α loop regulated NPC cell ferroptosis via transcriptional regulation of HILPDA expression. Moreover, the co-administration of Ang II receptor antagonist (ARB) and ferroptosis inducers markedly increased NPC radiosensitivity.Additionally, the expression of AGT, HIF-1α, and HILPDA was closely correlated with the intensity of ferroptosis, radiosensitivity, and prognosis in NPC.
Our findings suggest that the AGT-HIF-1α-HILPDA pathway promotes radioresistance in NPC by enhancing lipid droplet accumulation, thereby suppressing ferroptosis. Targeting local Ang II alongside ferroptosis induction offers a promising strategy to improve radiosensitivity in NPC.
放射治疗是鼻咽癌(NPC)的一种治愈性方法;然而,细胞放射敏感性的异质性限制了其疗效。因此,研究鼻咽癌放射抵抗的具体机制对于识别和使用有效的放射增敏剂以提高治疗成功率至关重要。
建立了放射抗性鼻咽癌细胞系HONE1-RR和SUNE1-RR。采用定量逆转录聚合酶链反应(qRT-PCR)、蛋白质免疫印迹法和酶联免疫吸附测定(ELISA)检测血管紧张素原(AGT)和局部血管紧张素II(Ang II)的激活情况。利用透射电子显微镜、亚铁离子检测和脂质氧化水平检测鼻咽癌中的辐射诱导铁死亡。采用生物信息学分析以及qRT-PCR、蛋白质免疫印迹法、免疫共沉淀和双荧光素酶测定来探索下游机制。采用集落形成试验、细胞计数试剂盒-8(CCK-8)试验和裸鼠异种移植模型评估鼻咽癌的放射敏感性。通过免疫组织化学检测鼻咽癌组织中AGT、缺氧诱导因子-1α(HIF-1α)、缺氧诱导脂滴相关蛋白(HILPDA)和谷胱甘肽过氧化物酶4(GPX4)的表达。
发现局部Ang II的激活在调节铁死亡从而驱动鼻咽癌细胞的放射抵抗中起关键作用。这种局部Ang II通过两条平行途径与HIF-1α建立了正反馈回路;Ang II通过激活丝裂原活化蛋白激酶(MAPK)途径使HIF-1α稳定,而AGT直接与HIF-1α结合以防止其降解。这个AGT-HIF-1α回路通过对HILPDA表达的转录调控来调节鼻咽癌细胞的铁死亡。此外,联合使用血管紧张素II受体拮抗剂(ARB)和铁死亡诱导剂可显著提高鼻咽癌的放射敏感性。此外,AGT、HIF-1α和HILPDA的表达与鼻咽癌中铁死亡的强度、放射敏感性和预后密切相关。
我们的研究结果表明,AGT-HIF-1α-HILPDA途径通过增强脂滴积累促进鼻咽癌的放射抵抗,从而抑制铁死亡。靶向局部Ang II并诱导铁死亡为提高鼻咽癌的放射敏感性提供了一种有前景的策略。